Splitting tumours into MCL1-low and MCL1-high groups confirmed that these stemness markers have elevated expression in MCL1-high tumours, which were also significantly enriched for ER-negative tumours (Fig. 5C and Supplementary Fig. 5D). This evidence concerns the gene MCL1 and neoplasm.